
Profound Medical Corp. PROF
Annual report 2023
added 12-27-2025
Profound Medical Corp. EV - Enterprise Value 2011-2026 | PROF
Annual EV - Enterprise Value Profound Medical Corp.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -13.5 M | -34.1 M | 169 M | 151 M | 107 M | 88.1 M | 13.7 M | 6.59 M | 5.21 M | 103 K | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 169 M | -34.1 M | 49.3 M |
EV - Enterprise Value of other stocks in the Medical devices industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Apollo Endosurgery
APEN
|
423 M | - | - | $ 475 M | ||
|
Allied Healthcare Products
AHPI
|
696 K | - | 3.58 % | $ 2.21 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
76.6 M | - | - | $ 1.77 B | ||
|
Axonics Modulation Technologies
AXNX
|
2.67 B | - | - | $ 3.31 B | ||
|
Acutus Medical
AFIB
|
40.9 M | - | -26.83 % | $ 2.62 M | ||
|
Lianluo Smart Limited
LLIT
|
655 M | - | 24.59 % | $ 44.8 M | ||
|
Cognyte Software Ltd.
CGNT
|
994 M | $ 7.22 | - | $ 518 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
-5.83 M | - | -5.86 % | $ 30.6 M | ||
|
Aziyo Biologics
AZYO
|
89.6 M | - | 1.37 % | $ 20.5 M | ||
|
Apyx Medical Corporation
APYX
|
54.4 M | $ 3.91 | -1.69 % | $ 135 M | ||
|
Alphatec Holdings
ATEC
|
1.41 B | $ 13.54 | -2.59 % | $ 1.94 B | ||
|
BIOLASE
BIOL
|
26.8 M | - | -13.19 % | $ 166 K | ||
|
Conformis
CFMS
|
3.84 M | - | - | $ 16.4 M | ||
|
Bio-Rad Laboratories
BIO
|
10.1 B | $ 294.76 | -1.65 % | $ 8.32 B | ||
|
Bruker Corporation
BRKR
|
3.81 B | - | 1.76 % | $ 6.31 K | ||
|
BioSig Technologies
BSGM
|
9.42 M | - | 37.08 % | $ 85.7 M | ||
|
CONMED Corporation
CNMD
|
3.26 B | $ 42.22 | -1.31 % | $ 1.3 B | ||
|
Boston Scientific Corporation
BSX
|
155 B | - | -0.69 % | $ 108 B | ||
|
Abbott Laboratories
ABT
|
228 B | - | 0.72 % | $ 197 B | ||
|
Cutera
CUTR
|
421 M | - | -10.19 % | $ 1.99 M | ||
|
Cardiovascular Systems
CSII
|
595 M | - | 0.15 % | $ 844 M | ||
|
CryoLife, Inc.
CRY
|
70.4 M | - | -4.14 % | $ 702 M | ||
|
ClearPoint Neuro
CLPT
|
459 M | $ 13.28 | -2.28 % | $ 359 M | ||
|
CHF Solutions, Inc.
CHFS
|
-7.7 M | - | 1.15 % | $ 34.5 M | ||
|
EDAP TMS S.A.
EDAP
|
252 M | $ 5.0 | 8.7 % | $ 186 M | ||
|
Dynatronics Corporation
DYNT
|
13.8 M | - | 14.99 % | $ 929 K | ||
|
Soliton, Inc.
SOLY
|
-100 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.54 B | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
427 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
-1.79 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
639 M | - | - | $ 111 M | ||
|
Intersect ENT, Inc.
XENT
|
1.02 B | - | - | $ 955 M | ||
|
InMode Ltd.
INMD
|
3.99 B | $ 14.26 | -2.67 % | $ 1.13 B | ||
|
Eargo
EAR
|
-53 M | - | - | $ 10.2 M | ||
|
Electromed
ELMD
|
170 M | - | - | $ 207 M | ||
|
Second Sight Medical Products
EYES
|
5.82 M | - | -0.97 % | $ 54.4 M | ||
|
Avinger
AVGR
|
17.3 M | - | -20.74 % | $ 369 K | ||
|
FONAR Corporation
FONR
|
91.5 M | $ 18.57 | -0.75 % | $ 122 M | ||
|
IRadimed Corporation
IRMD
|
629 M | $ 103.26 | - | $ 1.31 B | ||
|
GBS
GBS
|
6.89 M | - | -0.57 % | $ 7.12 M | ||
|
Integer Holdings Corporation
ITGR
|
5.99 B | $ 86.35 | - | $ 2.9 B | ||
|
Globus Medical
GMED
|
11.7 B | $ 88.28 | -0.37 % | $ 12 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
4.13 B | $ 11.05 | - | $ 851 M | ||
|
Pulmonx Corporation
LUNG
|
347 M | $ 1.45 | -0.34 % | $ 56.7 M | ||
|
Establishment Labs Holdings
ESTA
|
1.41 B | $ 72.06 | - | $ 2.03 B | ||
|
Medigus Ltd.
MDGS
|
11.2 M | - | 10.28 % | $ 55.5 M | ||
|
IRIDEX Corporation
IRIX
|
65.9 M | $ 1.43 | - | $ 23.1 M | ||
|
Invacare Corporation
IVC
|
-34.7 M | - | - | $ 24.7 M | ||
|
Cytosorbents Corporation
CTSO
|
87.4 M | $ 0.62 | -7.09 % | $ 33.7 M |